Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Watkins

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Archives Internationales De Pharmacodynamie Et De Therapie|April 1, 1987
Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril)T Baum, R W Watkins, E J Sybertz, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1981
Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalolT Baum, R W Watkins, E J Sybertz, et al.
Journal of Cardiovascular Pharmacology|December 1, 1996
Antiplatelet and antiproliferative effects of SCH 51866, a novel type 1 and type 5 phosphodiesterase inhibitorS Vemulapalli, R W Watkins, M Chintala, et al.
Journal of Cardiovascular Pharmacology|July 1, 1983
Antihypertensive activity of SCH 31846, a non-sulfhydryl angiotensin-converting enzyme inhibitorT Baum, E J Sybertz, R W Watkins, et al.
European Journal of Pharmacology|December 1, 2001
SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animalsG J Carey, W Billard, H Binch, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Archives Internationales De Pharmacodynamie Et De Therapie|April 1, 1987
Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril)T Baum, R W Watkins, E J Sybertz, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1981
Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalolT Baum, R W Watkins, E J Sybertz, et al.
Journal of Cardiovascular Pharmacology|December 1, 1996
Antiplatelet and antiproliferative effects of SCH 51866, a novel type 1 and type 5 phosphodiesterase inhibitorS Vemulapalli, R W Watkins, M Chintala, et al.
Journal of Cardiovascular Pharmacology|July 1, 1983
Antihypertensive activity of SCH 31846, a non-sulfhydryl angiotensin-converting enzyme inhibitorT Baum, E J Sybertz, R W Watkins, et al.
European Journal of Pharmacology|December 1, 2001
SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animalsG J Carey, W Billard, H Binch, et al.
Pageof 6